Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avinger Inc
(NQ:
AVGR
)
0.9604
-0.0296 (-2.99%)
Streaming Delayed Price
Updated: 9:51 AM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Avinger Inc
< Previous
1
2
3
Next >
Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium
April 28, 2023
Via
ACCESSWIRE
Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
April 26, 2023
Via
ACCESSWIRE
Avinger Reports Fourth Quarter 2022 Results
March 15, 2023
Via
ACCESSWIRE
Avinger to Announce Fourth Quarter 2022 Results on March 15
March 02, 2023
Via
ACCESSWIRE
Avinger Announces 510(k) Filing of Pantheris LV
January 11, 2023
Via
ACCESSWIRE
Avinger Reports Third Quarter 2022 Results
November 09, 2022
Via
ACCESSWIRE
Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices
November 04, 2022
Via
ACCESSWIRE
Avinger to Announce Third Quarter 2022 Results on November 9
November 01, 2022
Via
ACCESSWIRE
Avinger to Present at LD Micro Investor Conference
October 19, 2022
Via
ACCESSWIRE
Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022
September 01, 2022
Via
ACCESSWIRE
Avinger Reports Second Quarter 2022 Results
August 11, 2022
Via
ACCESSWIRE
Avinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market Under Nasdaq Rules
August 08, 2022
Via
ACCESSWIRE
Avinger to Announce Second Quarter 2022 Results on August 11
August 05, 2022
Via
ACCESSWIRE
Avinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
August 04, 2022
Via
ACCESSWIRE
Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System
July 06, 2022
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Exposures
Product Safety
Avinger Expands International Presence with First Commercial Shipment to Chile
June 21, 2022
REDWOOD CITY, CA / ACCESSWIRE / June 21, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022
June 15, 2022
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
June 06, 2022
REDWOOD CITY, CA / ACCESSWIRE / June 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany
May 16, 2022
REDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Reports First Quarter 2022 Results
May 10, 2022
REDWOOD CITY, CA / ACCESSWIRE / May 10, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,...
From
Avinger, Inc.
Via
AccessWire
Exposures
COVID-19
Product Safety
Avinger to Announce First Quarter 2022 Results on May 10
April 29, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Full Commercial Launch of Lightbox 3
April 19, 2022
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Issuance of Three New U.S. Patents in March 2022
March 30, 2022
16 New U.S. and International Patents Issued over Past Year REDWOOD CITY, CA / ACCESSWIRE / March 30, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and...
From
Avinger, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Avinger Regains Compliance with Nasdaq Listing Requirements
March 29, 2022
REDWOOD CITY, CA / ACCESSWIRE / March 29, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Avinger Reports Fourth Quarter and Year End 2021 Results
March 22, 2022
REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,...
From
Avinger, Inc.
Via
AccessWire
Avinger to Announce Full-Year 2021 Results on March 22
March 15, 2022
REDWOOD CITY, CA / ACCESSWIRE / March 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger to Effect One-for-Twenty Reverse Stock Split
March 14, 2022
REDWOOD CITY, CA / ACCESSWIRE / March 14, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Avinger Expands Lightbox 3 First Case Experience
March 07, 2022
Patients Treated in Four Additional Hospitals Using New Portable System REDWOOD CITY, CA / ACCESSWIRE / March 7, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Successful Completion of First Cases with the Lightbox 3 Next Generation Imaging Console
February 28, 2022
REDWOOD CITY, CA / ACCESSWIRE / February 28, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Closing of $7.6 Million Registered Direct Offering
January 14, 2022
REDWOOD CITY, CA / ACCESSWIRE / January 14, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
From
Avinger, Inc.
Via
AccessWire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.